Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens

Advancement in immunogen selection and vaccine design that will rapidly elicit a protective Ab response is considered critical for HIV vaccine protective efficacy. Vaccine-elicited Ab responses must therefore have the capacity to prevent infection by neutralization-resistant phenotypes of transmitte...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Immunol
Päätekijät: Hessell, Ann J., Malherbe, Delphine C., Pissani, Franco, McBurney, Sean, Krebs, Shelly J., Gomes, Michelle, Pandey, Shilpi, Sutton, William F., Burwitz, Benjamin J., Gray, Matthew, Robins, Harlan, Park, Byung S., Sacha, Jonah B., LaBranche, Celia C., Fuller, Deborah H., Montefiori, David C., Stamatatos, Leonidas, Sather, D. Noah, Haigwood, Nancy L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AAI 2016
Aiheet:
Immunotherapy and Vaccines
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4797725/
https://ncbi.nlm.nih.gov/pubmed/26944928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1500527
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia